Gyno-Pevaryl Depot (Econazole Nitrate)

Gyno-Pevaryl Depot is indicated for the treatment of fungal infections localized to the vagina.

• Management of acute vaginal candidiasis confirmed by clinical assessment.
• Treatment of recurrent yeast infections of the vagina when topical therapy is preferred.
• Adjunct therapy for mixed bacterial‑fungal vaginitis where an antifungal component is required.
• Use in patients who cannot tolerate oral azole antifungals due to systemic side effects.
• Prophylactic application after antibiotic therapy to reduce the risk of secondary yeast overgrowth.
• Treatment of vulvovaginal yeast infection in patients with diabetes when localized therapy is indicated.

The safety profile of Gyno-Pevaryl Depot reflects the typical local tolerability of vaginal imidazole antifungals, with most adverse events being mild and reversible.

Common

• Mild vaginal irritation or burning sensation.
• Transient itching or pruritus in the treated area.
• Discharge with a slight odor that resolves after treatment.
• Headache not directly related to the medication but reported by some users.
• Mild abdominal cramping or pelvic discomfort during application.
• Temporary increase in vaginal discharge volume.

Serious

• Allergic contact dermatitis presenting as redness, swelling, or rash.
• Severe vulvar edema or ulceration.
• Persistent or worsening vaginal symptoms suggesting secondary infection.
• Rare systemic hypersensitivity reactions such as fever, chills, or malaise.

Precautions for Gyno-Pevaryl Depot focus on patient selection, proper administration technique, and monitoring for unexpected reactions.

• Confirm diagnosis of vaginal candidiasis before initiating therapy.
• Avoid use in patients with known hypersensitivity to econazole or other imidazole antifungals.
• Do not insert the product if the vaginal mucosa is severely inflamed, ulcerated, or bleeding.
• Counsel patients to refrain from sexual intercourse or tampon use for a specified period after application.
• Assess for diabetes or immunocompromised conditions that may affect treatment response.
• Inform patients that the medication is for vaginal use only and should not be applied to other mucosal surfaces.
• Store the product at room temperature, protected from moisture and direct sunlight.

Gyno-Pevaryl Depot may interact with other agents applied vaginally or systemic drugs that affect fungal flora.

Avoid

• Concurrent use of other intravaginal antifungal or antiseptic products, which may reduce efficacy or increase irritation.
• Co‑administration with spermicidal agents that could alter mucosal absorption.
• Use of vaginal douches or cleansing solutions during treatment, which can wash away the medication.

Use with caution

• Systemic azole antifungals (e.g., fluconazole) as combined therapy may increase risk of hepatic enzyme interactions.
• Hormonal contraceptives delivered vaginally, as local irritation could affect absorption.
• Topical corticosteroids in the vagina, which may mask signs of infection.
• Patients receiving systemic immunosuppressants should be monitored, as fungal infections may progress despite topical therapy.
• Patients receiving systemic azole antifungals should be monitored for additive hepatic effects.